Table 1 Clinical and biochemical attributes of Oji-Cree at baseline and carotid measurements after 7 years
Diabetic subjects | Non-diabetic subjects | P-value | |
|---|---|---|---|
number/females | 49/26 | 49/26 | |
attributes at screening | |||
age (years) | 40.3 ± 1.8 | 40.4 ± 1.8 | NS (0.96) |
duration of diabetes (years) | 2.20 ± 0.62 | - | - |
current smokers (%) | 18.4 | 10.2 | NS (0.25) |
hypertensive (%) | 36.7 | 32.7 | NS (0.67) |
antihypertensive treatment (%) | 16.3 | 8.2 | NS (0.22) |
body mass index (kg/m2) | 29.6 ± 0.5 | 29.5 ± 0.6 | NS (0.75) |
waist circumference (cm) | 101 ± 1.4 | 99.8 ± 1.5 | NS (0.63) |
TC:HDL ratio | 4.95 ± 0.18 | 4.10 ± 0.17 | 0.0006 |
plasma triglycerides (mmol/L) | 2.25 ± 0.14 | 1.53 ± 0.11 | <0.0001 |
plasma glucose (mmol/L) | 10.79 ± 0.63 | 5.53 ± 0.07 | <0.0001 |
serum insulin (pmol/L) | 157 ± 12 | 133 ± 9 | NS (0.16) |
time elapsed since screening (years) | 7.34 ± 0.10 | 7.33 ± 0.10 | NS (0.96) |
mean IMT (μ m) | 795 ± 19 | 789 ± 26 | NS (0.49) |
mean TPV (mm3) | 109.9 ± 23.0 | 64.0 ± 17.0 | 0.037 |